Literature DB >> 1562041

Case report: cavernous hemangioma of the liver.

C T DuPre1, R M Fincher.   

Abstract

Although cavernous hemangioma is the most common benign tumor of the liver, controversy persists regarding diagnosis and management of these lesions. With the development of multiple noninvasive modalities to visualize the liver, hepatic cavernous hemangiomas are recognized with increased frequency. The authors report the unusual case of a post-menopausal woman on no exogenous estrogen therapy who had a cavernous hemangioma that remained stable for approximately 10 years before dramatically increasing in size. This patient illustrates the vague symptoms associated with cavernous hemangiomas and the unpredictability of growth. Although estrogens have been reported trophic, this patient had no exogenous or endogenous estrogen supply, yet her lesion reached massive proportions. Modalities necessary to assure accurate diagnosis and factors influential in management are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562041     DOI: 10.1097/00000441-199204000-00006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Enormous haemangioma of the liver.

Authors:  Rommel Zerpa; Eman Helmy Abdelghani; Gloria Iliescu; Carmen Escalante
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Cavernous hemangiomas of the liver: are there any indications for resection?

Authors:  O Farges; S Daradkeh; H Bismuth
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

3.  Interventional treatments for hepatic hemangioma: A state-of-the-art review.

Authors:  Kefeng Jia; Zhongsong Gao; Mingge Li; Changlu Yu
Journal:  J Interv Med       Date:  2022-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.